Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

NHS England will collect patient information on 100 genes linked to an increased risk of cancer, in a bid to identify those ...

A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published in Annals of Internal Medicine indicated.“We have developed a tool that can ...

ZERO Prostate Cancer (ZERO), announces the 2026 Veterans' Action Convening, a national gathering committed to strengthening prostate cancer care, support, and outcomes for veterans. Taking place ...

“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

Prostate cancer has now become the most prevalent cancer across the UK, new analysis reveals, surpassing breast cancer as the ...